Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (1): 181-184     DOI: 10.31083/j.rcm.2021.01.267
Case Report Previous articles | Next articles
Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic
Meor Azraai1, *(), Marcus McMahon2, Ronald Dick1
1Department of Cardiology, Epworth Healthcare, Melbourne, 3121 Victoria, Australia
2Department of Respiratory Medicine, Epworth Healthcare, Melbourne, 3121 Victoria, Australia
Download:  PDF(392KB)  ( 479 ) Full text   ( 52 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Amiodarone is a common antiarrhythmic drug that is utilised in clinical practice and is associated with pulmonary toxicity. The most common form of pulmonary complication is interstitial pneumonitis which is treated with discontinuation of amiodarone and initiation of corticosteroids. Amiodarone-induced pulmonary eosinophilia is a rare complication of amiodarone therapy, with blood and pulmonary eosinophilia the predominant features. During the COVID-19 era, the incidence of delay in treatment of pulmonary pathology is also delayed due to the effort of excluding COVID-19 infection. Here we report a case of a 64-year-old man who developed eosinophilic pneumonia after initiation of amiodarone therapy, and the investigations required to exclude other forms of pulmonary toxicity. We also reviewed the effect of COVID-19 testing in the management of patients presenting with respiratory distress.
Key words:  Amiodarone      Pulmonary eosinophilia      COVID-19      Amiodarone-induced pulmonary toxicity      Corticosteroids     
Submitted:  29 November 2020      Revised:  28 December 2020      Accepted:  29 December 2020      Published:  30 March 2021     
*Corresponding Author(s):  Meor Azraai     E-mail:  meor.azraaimeorahmad@epworth.org.au

Cite this article: 

Meor Azraai, Marcus McMahon, Ronald Dick. Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic. Reviews in Cardiovascular Medicine, 2021, 22(1): 181-184.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm.2021.01.267     OR     https://rcm.imrpress.com/EN/Y2021/V22/I1/181

[1] Peter A. McCullough, Raphael B. Stricker, Harvey A. Risch. Role of hydroxychloroquine in multidrug treatment of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 545-546.
[2] Matteo Beltrami, Simone Bartolini, Massimo Milli, Alberto Palazzuoli. The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 677-690.
[3] Matthieu MILLION, Jean-Christophe LAGIER, Hervé TISSOT-DUPONT, Isabelle RAVAUX, Catherine DHIVER, Christelle TOMEI, Nadim CASSIR, Léa DELORME, Sébastien CORTAREDONA, Sophie AMRANE, Camille AUBRY, Karim BENDAMARDJI, Cyril BERENGER, Barbara DOUDIER, Sophie EDOUARD, Marie HOCQUART, Morgane MAILHE, Coralie PORCHETO, Piseth SENG, Catherine TRIQUET, Stéphanie GENTILE, Elisabeth JOUVE, Audrey GIRAUD-GATINEAU, Herve CHAUDET, Laurence CAMOIN-JAU, Philippe COLSON, Philippe GAUTRET, Pierre-Edouard FOURNIER, Baptiste MAILLE, Jean-Claude DEHARO, Paul HABERT, Jean-Yves GAUBERT, Alexis JACQUIER, Stéphane HONORE, Katell GUILLON-LORVELLEC, Yolande OBADIA, Philippe PAROLA, Philippe BROUQUI, Didier RAOULT. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1063-1072.
[4] Lee Stoner, Mark Faghy, Ryan Conners. COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 263-265.
[5] Edoardo Pancaldi, Greta Pascariello, Giuliana Cimino, Angelica Cersosimo, Ludovica Amore, Fabio Alghisi, Nicola Bernardi, Emiliano Calvi, Carlo Mario Lombardi, Enrico Vizzardi, Marco Metra. Thrombotic risk in patients with COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 277-286.
[6] Ibrahim AlShahrani, Jagadish Hosmani, Vidya Gurram Shankar, Abdulaziz AlShahrani, Rafi Ahmad Togoo, Syed M Yassin, Shahrukh Khan, Shankargouda Patil. COVID-19 and cardiovascular system—a comprehensive review[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 343-351.
[7] Agata Bielecka-Dabrowa, Anna Cichocka-Radwan, Joanna Lewek, Filip Pawliczak, Marek Maciejewski, Maciej Banach. Cardiac manifestations of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 365-371.
[8] Paulino Alvarez, Alex Sianis, Jessica Brown, Abbas Ali, Alexandros Briasoulis. Chronic disease management in heart failure: focus on telemedicine and remote monitoring[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 403-413.
[9] Yu-Hao Zhao, Lei Zhao, Xin-Chun Yang, Pan Wang. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 159-165.
[10] Farah Yasmin, Syed Muhammad Shujauddin, Aisha Naeem, Adina Jabeen, Syed Muhammad Ismail Shah, Rohan Kumar Ochani, Osama Mohiuddin, Anosh Aslam Khan, Sumeen Jalees, Aminah Abdul Razzack, Shiza Salman, Shuja Abdul Karim Khan, Ahmad Mustafa, Hassan Mehmood Lak. Exploring the impact of the COVID-19 pandemic on provision of cardiology services: a scoping review[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 83-95.
[11] Qing Lu, Jiu-Long Wang, Zhi-Nan Chen, Wen-Bo Fu, Hui-Jian Liu, Shi-Fang Ding. The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 247-256.
[12] Andrew C. Berry, Russell S. Gonnering, Ivan Rodriguez, Qianying Zhang, Bruce B. Berry. Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 191-198.
[13] Ritu Thamman, Rajesh Janardhanan. Cardiac rehabilitation using telemedicine: the need for tele cardiac rehabilitation[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 497-500.
[14] Alexandru Burlacu, Radu Crisan-Dabija, Adrian Covic, Catalin Raiu, Ionut Mavrichi, Iolanda Valentina Popa, Manuel Lillo-Crespo. Pandemic lockdown, healthcare policies and human rights: integrating opposed views on COVID-19 public health mitigation measures[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 509-516.
[15] Peter A. McCullough, Paul E. Alexander, Robin Armstrong, Cristian Arvinte, Alan F. Bain, Richard P. Bartlett, Robert L. Berkowitz, Andrew C. Berry, Thomas J. Borody, Joseph H. Brewer, Adam M. Brufsky, Teryn Clarke, Roland Derwand, Alieta Eck, John Eck, Richard A. Eisner, George C. Fareed, Angelina Farella, Silvia N. S. Fonseca, Charles E. Geyer Jr., Russell S. Gonnering, Karladine E. Graves, Kenneth B. V. Gross, Sabine Hazan, Kristin S. Held, H. Thomas Hight, Stella Immanuel, Michael M. Jacobs, Joseph A. Ladapo, Lionel H. Lee, John Littell, Ivette Lozano, Harpal S. Mangat, Ben Marble, John E. McKinnon, Lee D. Merritt, Jane M. Orient, Ramin Oskoui, Donald C. Pompan, Brian C. Procter, Chad Prodromos, Juliana Cepelowicz Rajter, Jean-Jacques Rajter, C. Venkata S. Ram, Salete S. Rios , Harvey A. Risch, Michael J. A. Robb, Molly Rutherford, Martin Scholz, Marilyn M. Singleton, James A. Tumlin, Brian M. Tyson, Richard G. Urso, Kelly Victory, Elizabeth Lee Vliet, Craig M. Wax, Alexandre G. Wolkoff, Vicki Wooll, Vladimir Zelenko. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 517-530.
No Suggested Reading articles found!